A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.

Clinical trial NCT04808154 · COMPLETED

Trial details

NCT number: NCT04808154
Sponsor: Sinew Pharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis

Start date: 2021-07-22
Primary completion: 2021-08-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.